Canadian Journal of Cardiology publishes report on delayed vs. immediate coronary stenting
October 19, 2011 in Cardiology
The Canadian Journal of Cardiology has published a paper on the timing of coronary stenting, a thought-provoking paper that challenges one of the dogmas of acute heart attack management today.
Emergency procedures to open blocked coronary arteries in patients with acute myocardial infarction have revolutionized cardiology by preventing heart attacks and their complications. Stents (types of springs) are usually put into these arteries to keep them open after they have been unblocked by "clot-busting". The research presented in this paper provides data suggesting an alternative approach, one in which stents are not inserted immediately but several days after the intervention when the artery has had time to heal, may be superior. This idea counters much of present thinking.
In the editorial of the same issue, "From Primary to Secondary Percutaneous Coronary Intervention: The Emerging Concept of Early Mechanical Reperfusion With Delayed Facilitated StentingWhen Earlier May Not Be Better", Drs. E. Marc Jolicoeur and Jean-François Tanguay argue that this alternative intervention has much reason to be supported and that new thinking and testing are needed to improve management of patients with acute myocardial infarction.
"If the authors are right, we need to change how we manage some heart attack patients to give them a better chance for a successful outcome. Additional studies will allow us to know for sure, but in the meantime it is important that doctors managing heart attack patients consider these findings and their potential implications," comments Stanley Nattel, MD, Editor-in-Chief of the Canadian Journal of Cardiology.
More information: The paper is "Effect of Delayed vs. Immediate Stent Implantation on Myocardial Perfusion and Cardiac Function in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention With Thrombus Aspiration," by Liang Tang, MD, Sheng-hua Zhou, MD, PhD, Xin-qun Hu, MD, Zhen-fei Fang, MD, and Xiang-qian Shen, MD (doi:10.1016/j.cjca.2011.03.001). It appears in Canadian Journal of Cardiology, Volume 27, Issue 5 (September 2011)
Provided by Elsevier
-
New hidden heart attack culprit identified in women
Sep 26, 2011 |
not rated yet |
0
-
Risk of repeat attacks in heart patients causes concern for doctors
Aug 28, 2008 |
not rated yet |
0
-
Drug-releasing stents linked with decrease in procedures to unblock coronary arteries
Jun 25, 2008 |
not rated yet |
0
-
New technique for treating blocked coronary arteries shows promise
Feb 07, 2008 |
not rated yet |
0
-
Non-cardiac surgery too soon after stenting raises risk of heart problems
May 04, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
The Durability of Bone: Long Falls
5 hours ago
-
Is energy convertible to matter?
6 hours ago
-
Rotating electron as a dipole is this right?
9 hours ago
-
Dipole term in multipole expansion
13 hours ago
-
Bubbles in a Pre-Boiling/Boiling pot of water
14 hours ago
-
Assumptions of Griffith's fracture theory
May 21, 2013
- More from Physics Forums - Classical Physics
More news stories
Biodegradable stent proves non-inferior to drug-eluting stent
The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...
Cardiology
9 hours ago |
5 / 5 (1) |
0
Post-approval TAVI registry shows high rates of device success at one year
One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date – reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, ...
Cardiology
9 hours ago |
not rated yet |
0
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Cardiology
10 hours ago |
5 / 5 (1) |
0
|
Study identifies superior hypertension treatment, efficacy between sexes
(Medical Xpress)—In a recent subgroup analysis of the largest blood pressure treatment trial in history, University of Alabama at Birmingham (UAB) researchers found that women and men react the same to ...
Cardiology
18 hours ago |
5 / 5 (1) |
0
Evaluating a new way to open clogged arteries
Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments ...
Cardiology
19 hours ago |
4.6 / 5 (5) |
0
|
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Drugs found to both prevent and treat Alzheimer's disease in mice
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.